Diaceutics strengthens partnership with Partner Therapeutics
26th Mar 2025 11:41
(Sharecast News) - Diaceutics announced on Wednesday that it has strengthened its commercial partnership with Partner Therapeutics, the new US licence holder of the oncology precision medicine 'Bizengri', or zenocutuzumab, with an enhanced multi-year agreement for its PMx commercialisation services.
Read moreDiaceutics wins $5.1m contract with global pharma firm
17th Dec 2024 13:35
(Sharecast News) - Diaceutics announced on Tuesday that it has won a $5.1m contract with a global pharmaceutical company to deliver laboratory engagement services through its DXRX platform.
Read moreDiaceutics awarded £1m in UKRI funding
5th Dec 2024 13:23
(Sharecast News) - Diaceutics, a technology and solutions provider for the pharma and biotech sectors, announced on Thursday that it has been awarded £1m in grant funding from the UK Research Institute (UKRI) 'Strength in Places' fund.
Read moreDiaceutics reports progress in scaling US strategy
28th Nov 2024 10:28
(Sharecast News) - Pharmaceutical and biotechnology specialist Diaceutics announced significant progress in scaling its US commercial strategy on Thursday, through a series of data partnership agreements.
Read moreDiaceutics reports progress with rare-disease offerings
27th Aug 2024 12:24
(Sharecast News) - Diaceutics announced a significant enhancement to its rare-disease offerings on Tuesday, leading to the acquisition of a new contract aimed at supporting the commercialisation of a rare-disease therapy.
Read moreDiaceutics strikes 'groundbreaking' enterprise promotional partnership
19th Aug 2024 08:11
(Sharecast News) - Technology and solutions provider Diaceutics has struck a "groundbreaking enterprise promotional partnership" with a "leading biotech" firm worth up to £4.3m over 18 months.
Read moreDiaceutics strikes two new enterprise-wide agreements
16th May 2024 10:09
(Sharecast News) - Technology and solutions provider Diaceutics has struck two new enterprise-wide agreements, taking the total number to six engagements, across 29 separate therapeutic brands.
Read moreDiaceutics appoints new VP of marketing
9th Apr 2024 12:34
(Sharecast News) - Diaceutics, a technology and solutions provider catering to the pharmaceutical and biotech industry, announced the appointment of Amie Mc Neice as vice-president of marketing on Tuesday.
Read moreDirector dealings: BAT, Diaceutics execs make investments
6th Jun 2023 13:47
(Sharecast News) - Among the list of director buys on Tuesday was British American Tobacco, after its chief executive picked up more than a quarter-of-a-million pounds worth of shares.
Read moreDiaceutics shares resume trading after HSBC buys SVB UK
13th Mar 2023 11:10
(Sharecast News) - Pharmaceutical technology and service provider Diaceutics announced at mid-morning on Monday that the temporary suspension of its shares on AIM would be lifted.
Read moreDiaceutics secures $2m multi-year contract with global pharma company
13th Jun 2022 10:30
(Sharecast News) - Diagnostic commercialisation company Diaceutics has secured a multi-year contract win with an unnamed "top five" global pharmaceutical company to deliver customised data insights via its DXRX platform.
Read moreDiaceutics inks five-year deal with existing pharma partner
5th May 2022 12:58
(Sharecast News) - Diaceutics announced a five-year, multi-product subscription contract with an unnamed "top 30" global pharma company on Thursday, to deliver customised data insights via its 'DXRX' platform.
Read moreDiaceutics secures $1m subscription contract with 'leading life sciences company'
14th Dec 2021 09:45
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Tuesday that it had secured a $1.0m contract with a "leading life sciences company" to provide data feed from its DXRX platform.
Read moreDiaceutics delivers 'strong start' to 2021 despite ongoing pandemic
8th Jul 2021 09:56
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Thursday that it had delivered "a strong start to the 2021 financial year", in line with management's expectations and despite the ongoing Covid-19 pandemic.
Read moreDiaceutics secures multiple contracts with 'leading' pharma firms
24th Jun 2021 10:15
(Sharecast News) - Diagnostics commercialisation company Diaceutics has secured four contracts with two "leading pharmaceutical companies" to solve real-world testing hurdles for inherited retinal disease.
Read more